tiprankstipranks
Rosetta Genomics Ltd (ROSGQ)
OTHER OTC:ROSGQ
US Market

Rosetta Genomics (ROSGQ) Financial Statements

Compare
63 Followers

Rosetta Genomics Financial Overview

Rosetta Genomics's market cap is currently $593.00. The company's EPS TTM is $; its P/E ratio is ―; Rosetta Genomics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 16Dec 15Dec 14Dec 13Dec 12
Income Statement
Total Revenue
Gross Profit$ 1.79M$ 2.00M$ 17.00K$ -304.00K$ -57.00K
Operating Income$ -15.66M$ -15.88M$ -14.25M$ -13.35M$ -8.27M
EBITDA$ -15.32M$ -16.53M$ -13.95M$ -12.85M$ -10.10M
Net Income$ -16.23M$ -17.34M$ -14.53M$ -12.90M$ -10.46M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 11.96M$ 22.42M$ 17.28M$ 25.88M$ 32.53M
Total Debt$ 3.79M$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -2.37M$ -12.45M$ -7.93M$ -16.77M$ -30.80M
Total Liabilities$ 7.54M$ 2.80M$ 2.21M$ 2.25M$ 1.63M
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -10.59M$ -17.21M$ -13.85M$ -11.23M$ -8.91M
Operating Cash Flow$ -10.37M$ -16.93M$ -13.60M$ -10.61M$ -8.64M
Investing Cash Flow
Financing Cash Flow
Currency in USD

Rosetta Genomics Earnings and Revenue History

Rosetta Genomics Debt to Assets

Rosetta Genomics Cash Flow

Rosetta Genomics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis